Skip to content
Trial Eligibility
Menu

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

NCT04485286

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to investigate the efficacy of [68Ga]CBP8 to detect collagen deposition in radiation induced tissue injury.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lung Cancer
  • Radiation Fibrosis
  • Radiation Induced Lung Injury
  • Pancreas Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
February 27, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.